[Thromboembolisms endanger the internist patients, too: who needs heparin].
作者信息
Bischoff Angelika
出版信息
MMW Fortschr Med. 2006 Mar 16;148(11):21-2. doi: 10.1007/BF03364596.
PMID:16612959
Abstract
摘要
相似文献
1
[Thromboembolisms endanger the internist patients, too: who needs heparin].
MMW Fortschr Med. 2006 Mar 16;148(11):21-2. doi: 10.1007/BF03364596.
2
[Treatment of venous thromboembolism].
Med Clin (Barc). 2000 Jul 8;115(6):224-35. doi: 10.1016/s0025-7753(00)71516-8.
3
Selecting an agent for prophylaxis of venous thromboembolism.
Am J Health Syst Pharm. 2006 Dec 15;63(24):2448-50. doi: 10.2146/ajhp060231.
4
Low-molecular weight heparins.
J Ark Med Soc. 1997 Apr;93(11):555-6.
5
Low molecular weight heparins in acute coronary syndrome.
S D J Med. 2000 Jan;53(1):21-3.
6
[Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Med Clin (Barc). 1998 Nov 28;111(18):697-9.
7
[Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction].
Med Clin (Barc). 2000 Nov 4;115(15):583-6. doi: 10.1016/s0025-7753(00)71631-9.
8
When can the patient with deep venous thrombosis begin to ambulate?
Phys Ther. 2004 Mar;84(3):268-73.
9
[Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
MMW Fortschr Med. 2006 Jun 8;148(23):58-9.
10
[Evidence-based guidelines for prevention and therapy of venous thromboembolism].
Minerva Cardioangiol. 2000 Dec;48(12 Suppl 1):27-35.
Zotero 插件